In pancreatic ductal adenocarcinoma, several studies show that combining an MEK inhibitor, such as AZD6244, with PI3K inhibitor BKM120 or GDC0941, results in increased apoptosis, especially in pancreatic cell lines resistant to single agents [139]. The gene discussed is MAP2K7; the disease is pancreatic ductal adenocarcinoma.